Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • Daclatasvir is an HCV NS5A replication complex inhibitor that is approved for the treatment of HCV infection in the United States, Europe, and Japan

Action required